The sound of tumor cell-microenvironment communication – composed by the Cancer Cluster Salzburg research network.

Wessler, S; Aberger, F; Hartmann, TN; Cell Commun Signal. 2017; 15(1): 20

Prognostic score in patients with recurrent or metastatic carcinoma of the head and neck treated with cetuximab and chemotherapy.

Magnes, T; Melchardt, T; Weiss, L; Mittermair, C; Neureiter, D; Klieser, E; Gampenrieder, S; Moser, G; Gaggl, A; Greil, R; Egle, A; PLoS One. 2017; 12(7):e0180995

The first meeting of the Austrian Expert Panel for Molecular Cancer Profiling

Seeber, A; Gastl, G; Eisterer, W; Gampenrieder, SP; Gerger, A; Kieler, M; Pichler, M; Prager, GW; Untergasser, G; Weltermann, A; Greil, R MEMO-MAG EUR MED ONC. 2017; 10(4): 255-258.

Update on squamous cell carcinoma of the head and neck: ASCO annual meeting 2017.

Magnes, T; Egle, A; Greil, R; Melchardt, T; MEMO-MAG EUR MED ONC. 2017; 10(4): 220-223.

ASCO 2017-highlights of gynecological cancer.

Radl, B; Mlineritsch, B MEMO-MAG EUR MED ONC. 2017; 10(4): 237-239.

ASCO 2017-making a difference in cancer care with you

Rinnerthaler, G MEMO-MAG EUR MED ONC. 2017; 10(4): 187-189.

Lenalidomide Maintenance Compared With Placebo in Responding Elderly Patients With Diffuse Large B-Cell Lymphoma Treated With First-Line Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone.

Thieblemont, C; Tilly, H; Gomes da Silva, M; Casasnovas, RO; Fruchart, C; Morschhauser, F; Haioun, C; Lazarovici, J; Grosicka, A; Perrot, A; Trotman, J; Sebban, C; Caballero, D; Greil, R; van Eygen, K; Cohen, AM; Gonzalez, H; Bouabdallah, R; Oberic, L; Corront, B; Choufi, B; Lopez-Guillermo, A; Catalano, J; Van Hoof, A; Briere, J; Cabeçadas, J; Salles, G; Gaulard, P; Bosly, A; Coiffier, B; J CLIN ONCOL. 2017; 35(22): 2473-2481.

Azacitidine in adult patients with acute myeloid leukemia.

Schuh, AC; Dohner, H; Pleyer, L; Seymour, JF; Fenaux, P; Dombreth, H CRIT REV ONCOL HEMAT. 2017; 116: 159-177.

The Human NADPH Oxidase, Nox4, Regulates Cytoskeletal Organization in Two Cancer Cell Lines, HepG2 and SH-SY5Y.

Auer, S; Rinnerthaler, M; Bischof, J; Streubel, MK; Breitenbach-Koller, H; Geisberger, R; Aigner, E; Cadamuro, J; Richter, K; Sopjani, M; Haschke-Becher, E; Felder, TK; Breitenbach, M; Front Oncol. 2017; 7: 111

Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence – A Phase II Study.

Eisterer, W; Piringer, G; DE Vries, A; Öfner, D; Greil, R; Tschmelitsch, J; Samonigg, H; Sölkner, L; Gnant, M; Thaler, J; Anticancer Res. 2017; 37(5):2683-2691